Prader-Willi Syndrome (PWS) Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Prader-Willi Syndrome (PWS) Market is segmented By Growth Hormone Therapy (GENOTROPIN, NORDITROPIN, OMNITROPE), By Hyperphagia Treatment (DCCR, Carbetocin, ARD-101), By Behavioral and Sleep Management (WAKIX), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Competitive overview of Prader-Willi Syndrome (PWS) Market
The major players operating in the Prader-Willi Syndrome (PWS) market include Soleno Therapeutics, Harmony Biosciences, Pfizer, Novo Nordisk, Sandoz, ACADIA Pharmaceuticals, Aardvark Therapeutics, Gedeon Richter, Palobiofarma, and ConSynance Therapeutics.
Prader-Willi Syndrome (PWS) Market Leaders
- Soleno Therapeutics
- Harmony Biosciences
- Pfizer
- Novo Nordisk
- Sandoz
*Disclaimer: Major players are listed in no particular order.
Prader-Willi Syndrome (PWS) Market - Competitive Rivalry, 2023
Prader-Willi Syndrome (PWS) Market
Market Consolidated
(Dominated by major players)
(Dominated by major players)
Market Fragmented
(Highly competitive with lots of players.)
(Highly competitive with lots of players.)
*Source: Coherent Market Insights